NEW YORK, May 16, 2017 -- JLT Specialty USA, a U.S. subsidiary of Jardine Lloyd Thompson Group plc. (JLT), one of the world’s leading specialty-focused providers of insurance, reinsurance and employee benefits related advice, brokerage and associated services, is pleased to announce the appointment of Gabe Levitt as Executive Vice President.
Based in New York, Levitt will join JLT's New York office and focus on servicing private equity firms, real estate owner/developers, and other alternative investment groups across the U.S. His hire is a continuation of JLT’s growth strategy and expansion plans in the U.S. around key industries and product specialties.
Levitt brings to JLT more than 23 years of experience in and around the insurance industry. He began his career as an investment banker in the Financial Institutions Group at Goldman Sachs followed by eight years as an insurance and financial services private equity investor, primarily with Securitas Capital.
Levitt has spent the past 13 years in insurance brokerage, most recently with Krauter & Company, focused exclusively on sourcing and serving private equity and real estate clients as well as their respective portfolio companies/holdings.
Levitt graduated from the Wharton School at the University of Pennsylvania with a B.S. in Economics and concentration in Insurance and Risk Management.
“Gabe is a significant addition to our organization and we are excited to welcome him to the JLT team,” said Mike Rice, CEO at JLT Specialty USA. “Gabe’s experience will be an invaluable asset to the company and our clients.”
“We are pleased to welcome Gabe to JLT,” added David Payne, Chief Revenue Officer at JLT Specialty USA. “We are committed to bringing the best resources to our clients and Gabe’s appointment is yet another reflection of our ongoing dedication to hire top tier talent.”
NOTES TO EDITORS:
About Jardine Lloyd Thompson (JLT.L)
Jardine Lloyd Thompson is one of the world’s leading providers of insurance, reinsurance and employee benefits related advice, brokerage and associated services. JLT’s client proposition is built upon its deep specialist knowledge, client advocacy, tailored advice and service excellence.
JLT is quoted on the London Stock Exchange and owns offices in 40 territories with more than 10,600 employees. Supported by the JLT International Network, it offers risk management and employee benefit solutions in 135 countries.
For further information about JLT, please visit our website www.jlt.com and follow us on LinkedIn at JLT Group and Twitter @JLTGroup.
About JLT Specialty USA
JLT Specialty USA is the U.S. platform of the leading specialty business advisory firm, Jardine Lloyd Thompson Group. Our experts have deep industry and product experience serving leading U.S. and global firms. Our key to client success is our freedom to be creative, collaborative, and analytical while challenging conventions, redefining problems, creating new analytical insights, and exploring new boundaries to deliver solutions for each client’s unique business and risks.
For further information about JLT, please visit our website www.jltus.com and follow us on LinkedIn at JLT Specialty USA and Twitter @JLTSpecialtyUSA.
JLT ENQUIRIES: Name: Ashely Deal, VP of Marketing Phone: (310) 266-9464 Email: [email protected]


Anta Sports Expands Global Footprint With Strategic Puma Stake
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Samsung Electronics Shares Jump on HBM4 Mass Production Report
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Washington Post Publisher Will Lewis Steps Down After Layoffs
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



